Concepedia

Elizabeth Day

ED

6

Publications

684

Citations

6

H-Index

2003

Active since

Affiliations

Cambridge School(Current)

Novartis (United Kingdom)

Novartis (Switzerland)

Elizabeth Day is an author at Cambridge School specializing in fibrosis, engineering, and immunology.

ORCID

Top concepts

Publications per year

2003–2015

6

Publications

6

Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinib

Elizabeth Day, Beatrice Waters, Katrin Spiegel et al. · European Journal of Pharmacology · 2008 · 267 citations

, , +7

Rapid CD8+ T Cell Repertoire Focusing and Selection of High-Affinity Clones into Memory Following Primary Infection with a Persistent Human Virus: Human Cytomegalovirus

Elizabeth Day, Andrew Carmichael, Ineke J. M. ten Berge et al. · The Journal of Immunology · 2007 · 168 citations · Full text

TLR9 Differentiates Rapidly from Slowly Progressing Forms of Idiopathic Pulmonary Fibrosis

Glenda Trujillo, Alessia Meneghin, Kevin R. Flaherty et al. · Science Translational Medicine · 2010 · 155 citations · Full text

, , +21

Late diversification in the clonal composition of human cytomegalovirus-specific CD8+ T cells following allogeneic hemopoietic stem cell transplantation

Maher K. Gandhi, Mark R. Wills, Georgina Okecha et al. · Blood · 2003 · 56 citations · Full text

A functional analysis of Wnt inducible signalling pathway protein −1 (WISP-1/CCN4)

Sarah K. Stephens, Joanne Palmer, Irena Konstantinova et al. · Journal of Cell Communication and Signaling · 2015 · 25 citations · Full text

Rows per page

1–5 of 6